Patent · US Active

WT1 HLA class II-binding peptides and compositions and methods comprising same

US11548924B2 · kind B2 · utility

0Cited by

57References

17Claims

0Family size

Assignee

Memorial Sloan Kettering Cancer Center · US

Inventors

David A. Scheinberg · New York, US
Javier Pinilla-Ibarz · Tampa, US
Rena May · Baltimore, US

Key dates

Filing date	Feb 7, 2019
Grant date	Jan 10, 2023
Priority date	—
Expiry date	Aug 18, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/57
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides WT1 peptides and methods of treating, reducing the incidence of, and inducing immune responses against a WT1-expressing cancer, comprising same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.